Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy

@inproceedings{Bisaso2014CharacterizingPA,
  title={Characterizing plasma albumin concentration changes in TB/HIV patients on anti retroviral and anti –tuberculosis therapy},
  author={Kuteesa R. Bisaso and Joel S. Owen and Francis W. Ojara and Proscovia M Namuwenge and Apollo Mugisha and Lawrence Tanyi Mbuagbaw and Livingstone S. Luboobi and Jackson K. Mukonzo},
  booktitle={In Silico Pharmacology},
  year={2014}
}
Plasma albumin, a biomarker for hepatic function, is reported to correspondingly decrease in concentration as disease severity increases in chronic infections including HIV and TB. Our objective was to develop a semi-mechanistic disease progression model to quantify plasma albumin concentration changes during TB and HIV therapy and identify the associated covariate factors. Plasma albumin concentration data was collected at specified times for 3 months from 262 HIV participants receiving… CONTINUE READING